|
Development ::
Within a span of 5 years, the major achievements
to the credit of the Torrent Research Centre are
the development of world class fermentation technology
for Pen-G, synthesis of Omeprazole, Sparfloxacin,
Nicorandil, Lamotrigine, Sertraline, Sildenafil
Citrate, Repaglinide, Rosiglitazone,
Clopidogrel, Sibutramine and Cerivastatin and
the introduction of low dose combination of Lisinopril
and Hydrochlorothiazide(Listril Plus/Forte), matching
international quality standards. This rational
combination was specifically formulated keeping
in mind the needs of Indian patients.
First Time Introduction by the Centre
:
- Fluconazole 0.3% Eye Drops for the first
time in the world.
- Esomeprazole (20,40mg) Multi Unit Particulate
System (Pellets compressed in the form of tablet)
for the first time in India.
- Rosiglitazoe 2mg/4mg Immediate Release +
Metformin 500mg Sustanded - Release Dual Retard
Technology launched in the form of Inlay Tablet
for the first time of India.
- Few Non-Conventional Dosage Forms Developed.
| Dilzem CD (Diltiazem)
|
Controlled Release Pallets |
| Alprax Plus (Alprazolam
SR + Sertraline) |
Sustained Release + Immediate Release Bi
Component Capsule |
| Lamitor DT (Lamotrigine) |
Dispersible Tablet |
| Calcigard (Nifedipine) |
Soft Gelatin Capsule |
| Valparin Alkalets (Sodium
Valproate) |
Enteric Coated Tablet |
| Valparin Chrono (Sodium
Valproate) |
Sustained Release Matrix Tablet |
| Fegem (Iron Polymaltose
Complex) |
Chewable Tablet |
| Droxil Ready (Cefadroxil) |
Ready To Use Suspension |
| Dilzem Inj (Diltiazem) |
Life Saving Injectable |
| Nikoran IV (Nicorandil) |
Lyophilized Injectable |
| Nexpro (Esomeprazole) |
Pellets compressed in Tablet |
| Enselin MF (Rosiglitazone
IR+ Metformin SR) |
Dual Retard Technology in form of Inlay
Tablet |
Discovery Portfolio ::
Under the discovery program, the centre has found
some very promising molecules and patent applications
for these molecules have been filed in India,
under the PCT and the US.
|
